TickerRisk
Learn Pricing Open Scanner

GILEAD SCIENCES, INC. (GILD) Options Risk Score

Real-time risk analysis for GILD options traders — updated every 30 minutes.

100
HIGH Risk
87.9
IV Rank
40.6%
IV %
2026-10-29
Next Earnings
Biological Products, (No Diagnostic Substances)
Sector

Data last updated: 2026-10-21

Run a full GILD options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.


Scan GILD Now — Free →

Is it risky to sell options on GILEAD SCIENCES, INC. (GILD) right now?

Over a 4-week expiry window, GILEAD SCIENCES, INC. (GILD) scores 100 out of 100 for options catalyst risk (HIGH). The contributing signals are an upcoming earnings report, 4 recent news items, 7 active legal filings and 19 clinical-trial catalysts within the 4-week window. A HIGH reading (70+) means GILD has a dated event inside the window, so an option sold here carries gap risk that time decay alone will not pay for. The score ranks event exposure, not the likely direction of the move.

GILD shows an IV Rank of 88 — implied volatility is near the top of its own one-year range, so GILD options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 41%. IV Rank answers how GILD options are priced against their own history, which is the starting point for choosing between selling and buying premium.

The 2026-10-29 earnings report sits inside a standard monthly expiry for GILD, so implied volatility should stay bid into the date and drop sharply once it passes.

GILEAD SCIENCES, INC. (GILD) current implied volatility and IV Rank

GILEAD SCIENCES, INC. (GILD) currently has an IV Rank of 88 with implied volatility around 41%, alongside a TickerRisk options-risk score of 100/100. That sits near the top of its own 12-month range, so the chain is pricing richly. Sellers are being paid well here — but rich premium and a scheduled event usually arrive together, so check the catalyst list before writing anything.

For what this number does and does not tell you about GILD's options, see IV Rank explained.

GILEAD SCIENCES, INC. (GILD) next earnings date — 2026-10-29

GILEAD SCIENCES, INC. (GILD) reports earnings on 2026-10-29 — about 8 days away, which falls inside a typical options expiry window. GILD's IV Rank is currently 88. Earnings are the single biggest scheduled catalyst for an overnight gap: implied volatility usually runs up into the report and collapses immediately after (the IV crush). Selling premium into the event captures that crush but exposes you to the gap; buying premium needs a move large enough to beat the elevated IV you paid.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer